James Wolfe

1.4k total citations
28 papers, 1.1k citations indexed

About

James Wolfe is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, James Wolfe has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 18 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology and Allergy. Recurrent topics in James Wolfe's work include Asthma and respiratory diseases (16 papers), Inhalation and Respiratory Drug Delivery (14 papers) and Respiratory and Cough-Related Research (10 papers). James Wolfe is often cited by papers focused on Asthma and respiratory diseases (16 papers), Inhalation and Respiratory Drug Delivery (14 papers) and Respiratory and Cough-Related Research (10 papers). James Wolfe collaborates with scholars based in United States, Canada and Australia. James Wolfe's co-authors include Donald P. Tashkin, Michael Simmons, Barry Calvarese, Michael G. Genovesi, F. Eugene Holly, Michael B. Brachman, Barbara A. Prillaman, Harold S. Nelson, Leslie Baitinger and William W. Busse and has published in prestigious journals such as New England Journal of Medicine, JAMA and Neurology.

In The Last Decade

James Wolfe

27 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Wolfe United States 19 743 725 108 92 79 28 1.1k
Brian J. Lipworth United Kingdom 10 803 1.1× 856 1.2× 72 0.7× 6 0.1× 150 1.9× 10 1.2k
B J O'Connor United States 10 388 0.5× 343 0.5× 116 1.1× 93 1.0× 52 0.7× 12 769
N. Chronos United Kingdom 11 296 0.4× 74 0.1× 307 2.8× 14 0.2× 10 0.1× 28 765
Eleana Ntatsaki United Kingdom 10 376 0.5× 199 0.3× 57 0.5× 15 0.2× 14 0.2× 22 991
Adil Boz Türkiye 14 97 0.1× 89 0.1× 124 1.1× 19 0.2× 108 1.4× 41 508
Lars‐Eric Lins Sweden 14 123 0.2× 65 0.1× 123 1.1× 15 0.2× 23 0.3× 33 712
Toshiyuki Yamagata Japan 16 455 0.6× 225 0.3× 75 0.7× 5 0.1× 23 0.3× 34 767
Katie Casper United States 14 69 0.1× 302 0.4× 97 0.9× 33 0.4× 23 0.3× 35 750
Vaughan Ed United States 15 310 0.4× 76 0.1× 365 3.4× 28 0.3× 4 0.1× 30 912
Kang‐Cheng Su Taiwan 17 487 0.7× 369 0.5× 102 0.9× 4 0.0× 44 0.6× 43 746

Countries citing papers authored by James Wolfe

Since Specialization
Citations

This map shows the geographic impact of James Wolfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Wolfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Wolfe more than expected).

Fields of papers citing papers by James Wolfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Wolfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Wolfe. The network helps show where James Wolfe may publish in the future.

Co-authorship network of co-authors of James Wolfe

This figure shows the co-authorship network connecting the top 25 collaborators of James Wolfe. A scholar is included among the top collaborators of James Wolfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Wolfe. James Wolfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thompson, Bryony A., et al.. (2021). A homozygous truncating variant in GDF9 in siblings with primary ovarian insufficiency. Journal of Assisted Reproduction and Genetics. 38(6). 1539–1543. 6 indexed citations
2.
Solensky, Roland, Joshua Jacobs, Mitchell R. Lester, et al.. (2019). Penicillin Allergy Evaluation: A Prospective, Multicenter, Open-Label Evaluation of a Comprehensive Penicillin Skin Test Kit. The Journal of Allergy and Clinical Immunology In Practice. 7(6). 1876–1885.e3. 42 indexed citations
3.
Wenzel, Sally E., Robert W. Hopkins, Michael D. Saunders, et al.. (2014). Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, In Patients With Mild To Moderate Th2-Driven Asthma. Journal of Allergy and Clinical Immunology. 133(2). AB4–AB4. 14 indexed citations
4.
Dyck, P. James B., James W. Albers, James Wolfe, et al.. (2012). A trial of proficiency of nerve conduction: Greater standardization still needed. Muscle & Nerve. 48(3). 369–374. 37 indexed citations
5.
Koenig, Steven M., John Murray, James Wolfe, et al.. (2008). Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?. Respiratory Medicine. 102(5). 665–673. 22 indexed citations
6.
Wolfe, James, Craig LaForce, Bruce Friedman, et al.. (2006). Formoterol, 24 μg bid, and Serious Asthma Exacerbations. CHEST Journal. 129(1). 27–38. 29 indexed citations
7.
Nelson, Harold S., James Wolfe, Gary N. Gross, et al.. (2003). Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administeredin a hydrofluoroalkane metered-dose inhaleras an initial asthma maintenance treatment. Annals of Allergy Asthma & Immunology. 91(3). 263–269. 30 indexed citations
8.
Nathan, Robert A., Anjuli Nayak, David F. Graft, et al.. (2001). Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate. Annals of Allergy Asthma & Immunology. 86(2). 203–210. 44 indexed citations
9.
Shapiro, Gail, William R. Lumry, James Wolfe, et al.. (2000). Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma. American Journal of Respiratory and Critical Care Medicine. 161(2). 527–534. 176 indexed citations
10.
Wolfe, James, Paul Chervinsky, Michael B. Lawrence, et al.. (2000). Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma. Annals of Allergy Asthma & Immunology. 84(3). 334–340. 15 indexed citations
11.
Wolfe, James, Anthony R. Rooklin, James J. Grady, et al.. (2000). Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by Diskus device in patients with asthma treated with or without inhaled corticosteroids. Journal of Allergy and Clinical Immunology. 105(6). 1153–1161. 30 indexed citations
12.
Busse, William W., et al.. (1999). Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma. Journal of Allergy and Clinical Immunology. 103(6). 1075–1080. 113 indexed citations
13.
Kemp, James P., James Wolfe, James J. Grady, et al.. (1998). Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients. Clinical Therapeutics. 20(2). 270–282. 20 indexed citations
14.
15.
Lawrence, Michael B., et al.. (1997). Efficacy of Inhaled Fluticasone Propionate in Asthma Results from Topical and Not from Systemic Activity. American Journal of Respiratory and Critical Care Medicine. 156(3). 744–751. 58 indexed citations
16.
Wolfe, James, Gail G. Shapiro, & Paul H. Ratner. (1991). Comparison of Albuterol and Metaproterenol Syrup in the Treatment of Childhood Asthma. PEDIATRICS. 88(2). 312–319. 6 indexed citations
17.
Wolfe, James, et al.. (1982). Effect of daily aerosolized lodoxamide tromethamine in chronic asthmatics. Journal of Allergy and Clinical Immunology. 69(1). 153–153. 4 indexed citations
18.
Wolfe, James, Donald P. Tashkin, Barry Calvarese, & Michael Simmons. (1978). Bronchodilator Effects of Terbutaline and Aminophylline Alone and in Combination in Asthmatic Patients. New England Journal of Medicine. 298(7). 363–367. 134 indexed citations
19.
Wolfe, James & Daniel H. Simmons. (1977). Hemoptysis: diagnosis and management.. PubMed. 127(5). 383–90. 27 indexed citations
20.
Wolfe, James. (1976). The nature of the dream in The Great Gatsby..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian J. Lipworth Breakdown of academic impact, for papers by B J O'Connor Breakdown of academic impact, for papers by N. Chronos Breakdown of academic impact, for papers by Eleana Ntatsaki Breakdown of academic impact, for papers by Adil Boz Breakdown of academic impact, for papers by Lars‐Eric Lins Breakdown of academic impact, for papers by Toshiyuki Yamagata Breakdown of academic impact, for papers by Katie Casper Breakdown of academic impact, for papers by Vaughan Ed Breakdown of academic impact, for papers by Kang‐Cheng Su
Rankless by CCL
2026